TG Therapeutics Inc (NASDAQ:TGTX) traded at $20.44 at close of the session on Monday, July 22, made a downward move of -2.67% on its previous day’s price.
Looking at the stock we see that its previous close was $21.00 . The company has a trailing 12-month PE ratio of 92.70. In terms of its 52-week price range, TGTX has a high of $23.12 and a low of $6.46. The company’s stock has gained about 20.38% over that past 30 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
TG Therapeutics Inc has a market cap of $3.16 billion.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the TGTX stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy. Long term indicators on average place the stock in the category of 100% Buy.
Looking further, we note the current price level is 3.86% off its SMA20 and 14.16% from its 50-day simple moving average. The RSI (14) is pointing at 57.80 while the volatility over the past week is 5.70% and jumps to 5.57% over the past one month. The beta value is 2.23, while the average true range (ATR) is currently pointing at 1.01.
Coming back to TG Therapeutics Inc (NASDAQ:TGTX), we note that the average 3-month trading volume was 3.12 million. Current shares outstanding are 151.42 million.
The insiders hold 10.89% of the company’s shares while institutions hold 57.84%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 19.67% up in year-to-date price movement.
